Want to see IN:SOLARA full AI Analyst Report?
Solara Active Pharma Sciences Ltd. (SOLARA) Income Statement
Solara Active Pharma Sciences Ltd. Income Statement
Last quarter (Q2 2027), Solara Active Pharma Sciences Ltd.'s total revenue was $4.17B, an increase of 33.11% from the same quarter last year. In Q2, Solara Active Pharma Sciences Ltd.'s net income was $284.60M. See Solara Active Pharma Sciences Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 13.69B | $ 12.84B | $ 12.89B | $ 14.27B | $ 12.68B | |
| $ 3.66B | $ 6.57B | $ -1.30B | $ 1.25B | $ 5.60B | |
| $ 2.79B | $ 2.12B | $ 2.55B | $ 1.16B | $ 1.34B | |
| Depreciation and Amortization | $ 996.80M | $ 992.50M | $ 1.03B | $ 1.11B | $ 1.12B |
| $ 1.87B | $ 2.06B | $ -2.82B | $ 1.53B | $ 863.30M | |
| $ 870.70M | $ 4.46B | $ -3.85B | $ 85.60M | $ -332.80M | |
| $ -944.80M | $ -4.45B | $ -1.03B | $ -779.80M | $ -578.20M | |
| $ -74.10M | $ 5.40M | $ -4.88B | $ -448.10M | $ -911.00M | |
| $ -74.10M | $ 5.40M | $ -5.67B | $ -221.70M | $ -581.50M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.68 | $ 0.14 | $ -145.27 | $ -6.16 | $ -16.18 |
| Diluted EPS | $ -1.68 | $ 0.14 | $ -145.27 | $ -6.16 | $ -16.18 |
| Weighted Average Shares Outstanding | 44.11M | 38.57M | 39.06M | 36.00M | 35.94M |
| Weighted Average Shares Outstanding (Diluted) | 44.11M | 38.57M | 39.06M | 36.00M | 35.94M |
Currency in INR
